Business Daily Media

Men's Weekly

.

Sentinel Diagnostics Launches Two New Serological Tests To Quickly Assess The Immunoresponse To SARS-CoV-2

  • Written by PR Newswire
Sentinel Diagnostics Launches Two New Serological Tests To Quickly Assess The Immunoresponse To SARS-CoV-2

MILAN, May 4, 2021 /PRNewswire/ -- To quickly assess the immune response to SARS-CoV-2 of patients and entire communities, Sentinel Diagnostics - an Italian company focused for more than 35 years on the development and production of In Vitro Diagnostics for the most advanced Clinical Chemistry, Immunochemistry and Molecular Diagnostics platforms - announces the launch of two new serological tests for the detection of total antibodies (IgA, IgG and IgM) to SARS-CoV-2 specific proteins in human serum: COVID-19 Anti-S1 Total Ab and COVID-19 Anti-NC Total Ab.

The application of these tests would help to identify those individuals who have correctly developed antibodies after infection and/or vaccination, supporting the understanding of the degree of diffusion of COVID-19 in the community and the results of the efforts made by countries for vaccination campaigns. "The spread of the SARS-CoV-2 pandemic and the current ongoing vaccination campaigns have raised the need for quick evaluation of the immunological status of individuals and communities to understand what measures to adopt in order to avoid spreading of infection, but also to monitor the immune response after vaccination," explains Marco Buonaguidi, Head of Sales and Marketing. "We have developed our new quick solution that supports the continuous monitoring of epidemic to ensure public health decisions delivering fast results."

Both COVID-19 Anti-S1 Total Ab and COVID-19 Anti-NC Total Ab assays are In Vitro Diagnostic tests, for quantitative and qualitative analysis with immunoturbimetric method, designed to process hundreds of results in 1 hour and thousands in a single day when used on our Sentinel SENTIFIT®270 Analyzer or other automated analytical platforms. The first kit detects the total antibodies against the Spike RBD S1 protein, while the second detects the antibodies against Nucleocapsid (NC) protein.

The new Sentinel Diagnostics assays provide the first results in about 10 minutes. The use of Sentinel COVID-19 Anti-S1 Total Ab and COVID-19 Anti-NC Total Ab would help distinguish vaccinated individuals from naturally infected ones. The tests can be performed together on the same serum sample or separately to better fit with laboratory needs.

For more information, visit www.sentineldiagnostics.com[1].

Logo - https://mma.prnasia.com/media2/1502740/Sentinel_Diagnostics_Logo.jpg?p=medium600[2]

Read more https://www.prnasia.com/story/archive/3365075_AE65075_0

Demand for Home Batteries surges as Federal Rebate Kicks In

A leading provider of energy solutions VoltX Energy has seen a 400% increase in demand for home batteries in the past three weeks as people put d...

Why Sport Remains the Safest Bet in an Uncertain World

When Rome was in crisis, its leaders did not retreat to the Senate. They went to the circus. To the chariot races. To the gladiators. Sport was no...

THE FINE LINE WITHIN HILARIOUS SIGNAGE DESIGN FAILS

It seems like design failures still occur in today’s modern branding era, despite rigorous rounds of approvals behind the scenes. One signage show...

Deputy Announces Exclusive Global Partnership with Predelo to Bring AI to Shift-Based Businesses

Deputy, the global people platform for shift-based businesses, has announced an exclusive partnership with Predelo, an AI Decision Agent-as-a-Serv...

Leftover Budget? The Last-Minute EOFY Tip to Drive Business Success in FY25/26

The countdown is on. With just days left until EOFY, now’s the time to make your remaining 2024–2025 budget work harder and smarter. After workin...

pay.com.au appoints new CEO and Managing Director

The former COO will lead the company’s next growth phase, with ex-CEO Edward Alder transitioning into the role of Managing Director AUSTRALIA, 25...

Sell by LayBy